JP2015501791A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015501791A5 JP2015501791A5 JP2014540950A JP2014540950A JP2015501791A5 JP 2015501791 A5 JP2015501791 A5 JP 2015501791A5 JP 2014540950 A JP2014540950 A JP 2014540950A JP 2014540950 A JP2014540950 A JP 2014540950A JP 2015501791 A5 JP2015501791 A5 JP 2015501791A5
- Authority
- JP
- Japan
- Prior art keywords
- methoxyethyl
- gataparsen
- m5ru
- manufactured
- thoxyethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020110117082A KR101383324B1 (ko) | 2011-11-10 | 2011-11-10 | 신규한 유전자 전달용 조성물 |
| KR10-2011-0117082 | 2011-11-10 | ||
| PCT/KR2012/009443 WO2013070010A1 (en) | 2011-11-10 | 2012-11-09 | Novel composition for gene delivery |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015501791A JP2015501791A (ja) | 2015-01-19 |
| JP2015501791A5 true JP2015501791A5 (https=) | 2015-05-21 |
| JP5923177B2 JP5923177B2 (ja) | 2016-05-24 |
Family
ID=48290305
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014540950A Active JP5923177B2 (ja) | 2011-11-10 | 2012-11-09 | 新規な遺伝子伝達用組成物 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US9173853B2 (https=) |
| EP (1) | EP2776056B1 (https=) |
| JP (1) | JP5923177B2 (https=) |
| KR (1) | KR101383324B1 (https=) |
| ES (1) | ES2621403T3 (https=) |
| WO (1) | WO2013070010A1 (https=) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101494594B1 (ko) | 2011-08-30 | 2015-02-23 | 주식회사 종근당 | 약리학적 활성물질의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물 |
| KR101586791B1 (ko) | 2012-12-28 | 2016-01-19 | 주식회사 종근당 | ＧｎＲＨ 유도체의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물 |
| ES2642172T3 (es) | 2013-01-31 | 2017-11-15 | Chong Kun Dang Pharmaceutical Corp. | Compuestos derivados de ciclohexeno sustituidos con biarilo o biarilo heterocíclico como inhibidores de CETP |
| KR101601035B1 (ko) | 2013-02-28 | 2016-03-08 | 주식회사 종근당 | 키토산 및 액상결정 형성 물질을 포함하는 유전자 전달용 조성물 |
| CL2014003514A1 (es) * | 2014-12-23 | 2015-05-08 | Univ De Concepción | Nanopartículas a base de quitosano para el transporte de péptidos con actividad en el sistema nervioso central. |
| KR101916193B1 (ko) * | 2016-08-25 | 2018-11-07 | 주식회사 파마리서치프로덕트 | 핵산 및 키토산을 포함하는 관절강 주사용 조성물 |
| CA3060514A1 (en) | 2017-04-20 | 2018-10-25 | Atyr Pharma, Inc. | Compositions and methods for treating lung inflammation |
| AU2019247511B2 (en) | 2018-04-06 | 2025-10-16 | Atyr Pharma, Inc. | Compositions and methods comprising anti-NRP2 antibodies |
| DK4257600T3 (da) | 2018-07-03 | 2025-05-26 | Gilead Sciences Inc | Antistoffer rettet mod hiv gp120 og fremgangsmåder til at bruge dem |
| JP7490925B2 (ja) | 2018-07-26 | 2024-05-28 | エータイアー ファーマ， インコーポレイテッド | Ｎｒｐ２関連疾患を治療するための組成物および方法 |
| WO2020263830A1 (en) | 2019-06-25 | 2020-12-30 | Gilead Sciences, Inc. | Flt3l-fc fusion proteins and methods of use |
| KR20240137107A (ko) | 2019-07-16 | 2024-09-19 | 길리애드 사이언시즈, 인코포레이티드 | Hiv 백신, 및 이의 제조 및 사용 방법 |
| DK4037708T3 (da) | 2019-09-30 | 2024-09-30 | Gilead Sciences Inc | HBV-vacciner og fremgangsmåder til at behandle HBV |
| CA3128035A1 (en) | 2020-08-13 | 2022-02-13 | Bioasis Technologies, Inc. | Combination therapies for delivery across the blood brain barrier |
| TW202406932A (zh) | 2020-10-22 | 2024-02-16 | 美商基利科學股份有限公司 | 介白素2-Fc融合蛋白及使用方法 |
| CA3259040A1 (en) | 2022-07-12 | 2024-01-18 | Gilead Sciences, Inc. | HIV Immunogenic Polypeptides and Vaccines and Their Uses |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6008202A (en) | 1995-01-23 | 1999-12-28 | University Of Pittsburgh | Stable lipid-comprising drug delivery complexes and methods for their production |
| US7052678B2 (en) | 1997-09-15 | 2006-05-30 | Massachusetts Institute Of Technology | Particles for inhalation having sustained release properties |
| WO1999036089A1 (en) * | 1998-01-16 | 1999-07-22 | The Johns Hopkins University | Genetic immunization with co-delivery of nucleic acid and cytokines in a single vehicle |
| US20030134810A1 (en) | 2001-10-09 | 2003-07-17 | Chris Springate | Methods and compositions comprising biocompatible materials useful for the administration of therapeutic agents |
| CA2516188C (en) * | 2003-02-14 | 2012-04-17 | University Of South Florida | Chitosan-derivatives for gene delivery and expression |
| KR100882611B1 (ko) * | 2006-11-14 | 2009-02-12 | 주식회사 키토라이프 | 표적 리간드로서 폴릭산이 도입된 유전자 전달체용저분자량 수용성 키토산 나노입자 및 이의 제조방법 |
| KR100825519B1 (ko) * | 2007-01-05 | 2008-04-25 | 주식회사 바이오폴리메드 | 키토산 기재 고분자 접합체 및 그 제조방법 |
| CA2710983A1 (en) | 2007-12-27 | 2009-10-01 | The Ohio State University Research Foundation | Lipid nanoparticle compositions and methods of making and using the same |
| KR101494594B1 (ko) | 2011-08-30 | 2015-02-23 | 주식회사 종근당 | 약리학적 활성물질의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물 |
-
2011
- 2011-11-10 KR KR1020110117082A patent/KR101383324B1/ko active Active
-
2012
- 2012-11-09 US US14/357,375 patent/US9173853B2/en active Active
- 2012-11-09 JP JP2014540950A patent/JP5923177B2/ja active Active
- 2012-11-09 WO PCT/KR2012/009443 patent/WO2013070010A1/en not_active Ceased
- 2012-11-09 ES ES12847217.2T patent/ES2621403T3/es active Active
- 2012-11-09 EP EP12847217.2A patent/EP2776056B1/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015501791A5 (https=) | ||
| Xiong et al. | Amphiphilic block co-polymers: preparation and application in nanodrug and gene delivery | |
| JP2013542247A5 (https=) | ||
| JP2013507423A5 (https=) | ||
| WO2014004436A3 (en) | Crystalline anti-human il-23 antibodies | |
| EA201890236A1 (ru) | Полициклические карбамоилпиридоновые соединения и их фармацевтическое применение | |
| PH12014502524A1 (en) | Carboxylic acid compounds | |
| BR112014014599A2 (pt) | polímeros de alfa-aminoamidina e uso dos mesmos | |
| SG10201804024VA (en) | Formulations of azaindole compounds | |
| WO2014066468A8 (en) | Stable, low viscosity antibody formulation | |
| GEP201706780B (en) | Substituted 2-aza-bicyclo [2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin c | |
| JP2011105738A5 (https=) | ||
| MD20140073A2 (en) | New phosphate compounds, a process for their preparation and pharmaceutical compositions containing them | |
| JP2015007131A5 (https=) | ||
| MA35130B1 (fr) | Composition comprenant de l'aflibercept, de l'acide folinique, du 5-fluoro-uracile (5-fu) et de l'irinocetan (folfiri) | |
| JP2014097964A5 (https=) | ||
| MY178888A (en) | Dialysis a agent comprising acetic acid and acetate, and two-part dialysis agent using same | |
| CA2920410C (en) | Thienopiperidine derivative and use thereof | |
| JP2015509075A5 (https=) | ||
| JP2013518036A5 (https=) | ||
| JP2013535445A5 (https=) | ||
| BR112012008666A2 (pt) | processo para a preparação de um pó, formulação, e, uso do pó preparado por um processo | |
| WO2014081968A8 (en) | Compositions of low sodium salt and methods of making and using | |
| BR112014017163A2 (pt) | composição de colírio | |
| JP2014500250A5 (https=) |